Analgesia Clinical Trial
Official title:
Investigating Potential Determinants of Breast-Feeding Probability: Epidural Analgesia, Beta-Endorphin Concentrations in Colostrum, and Infant Feeding Behavior
Presently, the literature addressing the relationship between epidural analgesia and
likelihood of breast-feeding is inconclusive. Numerous studies have found that epidurals,
administered prior to vaginal delivery of a full-term, healthy neonate, significantly
decrease lactation success at follow-up times ranging from 24 hours to 6 months postpartum.
One proposed mechanism is that analgesics, by decreasing maternal pain during labor, decrease
maternal endorphin production and result in the transmission of lower endorphin levels to the
neonate during breast-feeding. Lower endorphin levels, in turn, may render the neonate less
likely to suckle optimally. Other studies have found that epidural analgesia does not
significantly decrease lactation success when used during the vaginal delivery of a
full-term, healthy neonate.
Although most studies to date have compared the breast-feeding success of epidural recipients
and non-recipients at various points postpartum, they do not specifically note whether
deficient feeding behaviors on the part of the infant contribute to failed breast-feeding.
The present study uses the LATCH assessment tool to score the infant's ability to latch onto
the breast and the presence of audible swallowing, as well as the mother's level of physical
comfort with breast feeding, whether she can successfully position the infant for feeding on
her own, and whether her nipples are inverted, everted, or flat. Thus, the LATCH assessment
enables the separation of multiple factors that may contribute to breast-feeding failure. A
multivariate regression analysis will determine how strongly the probability of
breast-feeding at hospital discharge correlates with epidural duration, LATCH scores, and
beta-endorphin concentrations in colostrum.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05534230 -
Dexmedetomidine for Pain Reduction in CABG
|
N/A | |
Recruiting |
NCT06275698 -
HONEY for the Treatment of POst-Tonsillectomy Pain
|
N/A | |
Recruiting |
NCT04436224 -
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
|
Phase 4 | |
Not yet recruiting |
NCT04548323 -
Hypoalgesic Effects of Walking and Running Imagined
|
||
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT04394481 -
Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery
|
Phase 4 | |
Completed |
NCT04690647 -
The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.
|
N/A | |
Completed |
NCT05034601 -
ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure
|
N/A | |
Completed |
NCT03740815 -
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
|
N/A | |
Recruiting |
NCT05454202 -
Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
|
||
Recruiting |
NCT04554186 -
Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.
|
N/A | |
Suspended |
NCT04860635 -
Safety of F14 Following Total Knee Replacement
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06393777 -
Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion
|
N/A | |
Not yet recruiting |
NCT04519463 -
The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
|
Early Phase 1 | |
Completed |
NCT02916342 -
Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks
|
Phase 4 | |
Completed |
NCT03206554 -
Local Infiltration Analgesia in Total Knee Arthroplasty
|
Phase 2 | |
Not yet recruiting |
NCT02549118 -
Tenoxicam for Intrapartum Analgesia
|
Phase 2 | |
Not yet recruiting |
NCT02190760 -
Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block.
|
N/A | |
Completed |
NCT01789606 -
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
|
Phase 3 | |
Completed |
NCT01299584 -
ULTIVA Post Marketing Surveillance
|
N/A |